Blood Coagulation Tubes Market Analysis
The transformation of blood from a fluid state to a thick, jelly-like state known as a clot is known as blood coagulation or clotting. Hemostasis is the term used to describe this process, which serves to prevent blood loss from injured blood vessels. Platelet activation, aggregation, and fibrin deposition and formation are all part of the coagulation process. Coagulation disorders such as thrombosis and hemorrhage are significant concerns.
𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗛𝗲𝗿𝗲 𝗙𝗼𝗿 𝘁𝗵𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 @ https://www.coherentmarketinsights.com/insight/request-sample/139
Coagulation tests are primarily used to measure the ability of plasma to clot, as well as the time it takes to do so. These tests aid physicians in assessing the risk of severe bleeding or the development of thrombosis within blood vessels. Coagulation testing is carried out in a similar manner to most blood tests and has minimal side effects. Coagulation disorders can cause dangerous amounts of blood loss or excessive clotting. If a coagulation disorder is suspected, additional coagulation tests may be performed to confirm the diagnosis. These tests are valuable for measuring the functions of numerous proteins. Conditions that can cause clotting disorders include liver disease, thrombophilia (excessive clotting), and hemophilia (inability to clot normally). Additionally, coagulation tests are beneficial for individuals taking medications that affect their blood coagulation ability. Depending on the patient’s history and condition, coagulation tests may also be conducted prior to certain surgical procedures.
The primary solution contained in blood coagulation tubes is trisodium citrate. These tubes are available in two different concentrations of citrate: 0.129 mol/L (3.8%) and 0.109 mol/L (3.2%). The recommended mixing ratio is typically one part citrate to nine parts blood. Additionally, adenosine, theophylline, and dipyridamole are also present in these tubes. It is important to note that these tubes must be completely filled, as under-filled tubes may not serve the intended purpose. The side effects of a coagulation test are usually minor, with patients experiencing slight soreness or bruising at the site. Other potential risks include dizziness, pain, and the possibility of infection.
Blood Coagulation Tubes Taxonomy
The global market for blood coagulation tubes is categorized based on the concentration of citrate as:
- 8% citrate solution
- 2% citrate solution
Furthermore, the global market for blood coagulation tubes is classified by the type of end-user as:
- Diagnostic Centers
- Medical Practitioners
The global blood coagulation tubes market is expected to grow significantly during the forecast period (2016-2024) due to the increasing awareness of health among the global population, which has led to a rise in blood diagnostic tests, particularly coagulation tests. The market’s growth is also supported by factors such as the increasing prevalence of low platelet count or thrombocytopenia, a higher incidence of liver diseases, and an increase in the number of surgeries.
𝐁𝐮𝐲 𝐍𝐨𝐰, 𝐆𝐞𝐭𝐭𝐢𝐧𝐠 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 (𝐔𝐩 𝐓𝐨 𝟒𝟓% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭) 𝐜𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/promo/buynow/139
Increasing thrombosis and liver disease prevalence is a key factor in the growth of the worldwide blood coagulation tubes market.
The American Liver Foundation reported that in 2013, liver disease affected approximately 30 million people in the United States, which accounts for 10% of the population. In England and Wales, liver disease is considered the “fifth big killer,” according to the WHO-HFA database. To diagnose thrombosis, blood coagulation tubes are widely used. The Center for Disease Control and Prevention (CDC) estimates that up to 900,000 individuals in the United States experience thrombosis annually. Bleeding disorders are evaluated by testing fibrinogen activity, which is also used to diagnose diseases such as disseminated intravascular coagulation. The University of Alabama at Birmingham’s Department of Medicine reported that fibrinogen levels in South Asia, particularly India, are usually high due to an increased prevalence of coronary heart disease and wound-induced glycoprotein IIb/IIIa, which acts as a receptor for fibrinogen. This results in an increased number of blood coagulation tests in the region, creating a favorable environment for the growth of the blood coagulation tubes industry. The Journal of Thrombosis and Hemostasis emphasizes the need for controlled and randomized assessments with clinical result measurement to establish the necessity of thromboprophylaxis in joint surgery in Asia. The growth in the number of surgeries is expected to provide significant growth to the blood coagulation tubes market since blood coagulation tests are typically recommended before and after surgery. Independent estimates indicate that approximately 232 million surgeries are performed worldwide each year. The highest revenue contributors to the global blood clotting tubes market are Europe and North America, primarily due to their robust healthcare infrastructure and easy access to advanced healthcare facilities. However, the Asia Pacific region is expected to emerge as a high-growth region in the global blood coagulation market due to the increasing adoption of blood coagulation tests and the high prevalence of heart attacks and strokes, as well as the rising incidence of thrombosis and chronic liver diseases in the region.
Medical Expo, Ajosha BioTeklik Pvt. Ltd., CML Biotech Pvt. Ltd., New MicroMed International Pvt. Ltd., Greiner BioOne, Gosselin, FL Medical, and Advacare Pharma are among the prominent players in the blood coagulation tubes market.
The blood coagulation tubes industry is anticipated to experience growth due to the introduction of new products and ongoing advancements by major market participants. One such example is Q-Sera Pty Ltd., a medical device company, which disclosed in August 2019 that their Q-Sera technology, a blood clotting technology for use in blood collection tubes, was granted a patent by the United States Patent & Trademark Office.
Table of Content
Global Blood Coagulation Tubes Market Research Report
Section 1: Global Blood Coagulation Tubes Industry Overview
Section 2: Global Economic Impact on Blood Coagulation Tubes Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Blood Coagulation Tubes Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Blood Coagulation Tubes Market Forecast
𝗚𝗲𝘁 𝘆𝗼𝘂𝗿 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 @ https://www.coherentmarketinsights.com/insight/request-customization/139
Check Out More Related Reports:
Hospital information system market
Electrophysiology devices market
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Phone: U.S.: +1-206-701-6702